Lindner A , Charra B , Sherrard DJ , et al.. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290:697–701.
Ferrer Tomas R , Jara J Guías SEN. Riñón y Enfermedad Cardiovascular 2004; 24:21–26.
Bover J , Ortiz F , Cabezas A , et al.. Nuevos conceptos sobre enfermedad renal crónica y sus implicaciones, Act Fund Puigvert 2004; 23:176–191.
Pérez SG , Ortiz F , Ballarín J , Bover J . Enfermedad cardiovascular en pacientes con enfermedad renal crónica: modelo experimental para la evaluación del eje cardio-renal. Act Fund Puigvert 2006; 25:189–194.
Ronco C , Haapio M , House AA , et al.. Cardiorenal syndrome, J Am Coll Cardiol 2008; 52:1527–1539.
Levey AS , Beto JA , Coronado BE , et al.. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998; 32:853–906.
Sarnak MJ , Levey AS , Schoolwerth AC , et al.. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108:2154–2169.
Foley RN , Parfrey PS , Harnett JD , et al.. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49:1379–1385.
K/DOQI clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1–266.
Levey AS , Eckardt KU , Tsukamoto Y , et al.. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67:2089–2100.
The Seventh Report of the Joint National Committee on Prevention , Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). Hypertension 2003; 42:1206–1252.
Gracia S , Montañés R , Bover J , et al.. Recommendations for the use of equations to estimate glomerular filtration rate in adults. Spanish Society of Nephrology. Nefrologia 2006; 26:658–665.
Foley RN , Parfrey PS , Sarnak MJ : Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9(12 Suppl).
Bover J , Górriz JL , Martín de Francisco AL , et al.. Unawareness of the K/DOQI guidelines for bone and mineral metabolism in predialysis chronic kidney disease: results of the OSERCE Spanish multicenter-study survey. Nefrologia 2008; 28:637–643.
Dikow R , Kihm LP , Zeier M , et al.. Increased infarct size in uremic rats: reduced ischemia tolerance? J Am Soc Nephrol 2004; 15:1530–1536.
van Dokkum RP , Eijkelkamp WB , Kluppel AC , et al.. Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction. J Am Soc Nephrol 2004; 15:3103–3110.
Fernández-Llama P , Bover J . Is albuminuria a marker of arterial remodeling? J Hypertens 2008; 26:633–635.
Ochodnicky P , de Zeeuw D , Henning RH , et al.. Endothelial function predicts the development of renal damage after combined nephrectomy and myocardial infarction. J Am Soc Nephrol 2006; 17(4 Suppl 2):S49–52.
Fedulov AV , Ses TP , Gavrisheva NA , et al.. Serum TGF-β 1 and TNF-alpha levels and cardiac fibrosis in experimental chronic renal failure. Immunol Invest 2005; 34:143–152.
Wong LS , Windt WA , Roks AJ , et al.. Renal failure induces telomere shortening in the rat heart. Neth Heart J 2009 May; 17(5):190–194.
Brymora A , Flisiński M , Grześk G , et al.. Inflammation, malnutrition and vascular contraction in experimental chronic kidney disease. J Nephrol 2007; 20:423–429.
Pérez S , Bernasconi A , Ballarín J , et al.. La enfermedad cardiovascular en pacientes con insuficiencia renal crónica: el eje cardiorenal. Rev Argent Cardiol 2008; 76:215–218.
Pérez S , Ortiz F , Ballarín J , Bover J . Enfermedad cardiovascular en pacientes con enfermedad renal crónica: modelo experimental para la evaluación del eje cardio-renal. Act Fund Puigvert 2006; 25(4):189–194.
Buzello M , Torniq J , Faulhaber J , et al.. The apolipoprotein E knockout mouse: a model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol 2003; 14:311–316.
Davies MR , Lund RJ , Mathew S , Hruska KA . Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. JAm Soc Nephrol 2005; 16:917–928.
Li Y , Takemura G , Okada H , et al.. Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure. J Card Fail 2007; 13:155–162.